In early 2021, as COVID-19 vaccines were being rolled out across the world, reports began to surface of a rare but alarming complication. Some people who received the shots were developing unusual ...

CRF awards four global grants to advance CHM research toward new clinical trial endpoints and therapeutic approaches—driving progress toward treatments.

Absci (NASDAQ:ABSI) used a presentation at the Leerink Partners Global Healthcare Conference to outline how the company is applying its internal AI-driven drug design platform to generate ...